-
Je něco špatně v tomto záznamu ?
Injectable hydroxyphenyl derivative of hyaluronic acid hydrogel modified with RGD as scaffold for spinal cord injury repair
K. Zaviskova, D. Tukmachev, J. Dubisova, I. Vackova, A. Hejcl, J. Bystronova, M. Pravda, I. Scigalkova, R. Sulakova, V. Velebny, L. Wolfova, S. Kubinova,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
29266693
DOI
10.1002/jbm.a.36311
Knihovny.cz E-zdroje
- MeSH
- hydrogely chemie MeSH
- injekce * MeSH
- kyselina hyaluronová chemie MeSH
- lidé MeSH
- messenger RNA genetika metabolismus MeSH
- mezenchymální kmenové buňky cytologie účinky léků MeSH
- oligopeptidy chemie MeSH
- pohybová aktivita MeSH
- poranění míchy patologie patofyziologie MeSH
- potkani Wistar MeSH
- regenerace míchy * MeSH
- tkáňové podpůrné struktury chemie MeSH
- Whartonův rosol cytologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Hydrogel scaffolds which bridge the lesion, together with stem cell therapy represent a promising approach for spinal cord injury (SCI) repair. In this study, a hydroxyphenyl derivative of hyaluronic acid (HA-PH) was modified with the integrin-binding peptide arginine-glycine-aspartic acid (RGD), and enzymatically crosslinked to obtain a soft injectable hydrogel. Moreover, addition of fibrinogen was used to enhance proliferation of human Wharton's jelly-derived mesenchymal stem cells (hWJ-MSCs) on HA-PH-RGD hydrogel. The neuroregenerative potential of HA-PH-RGD hydrogel was evaluated in vivo in acute and subacute models of SCI. Both HA-PH-RGD hydrogel injection and implantation into the acute spinal cord hemisection cavity resulted in the same axonal and blood vessel density in the lesion area after 2 and 8 weeks. HA-PH-RGD hydrogel alone or combined with fibrinogen (HA-PH-RGD/F) and seeded with hWJ-MSCs was then injected into subacute SCI and evaluated after 8 weeks using behavioural, histological and gene expression analysis. A subacute injection of both HA-PH-RGD and HA-PH-RGD/F hydrogels similarly promoted axonal ingrowth into the lesion and this effect was further enhanced when the HA-PH-RGD/F was combined with hWJ-MSCs. On the other hand, no effect was found on locomotor recovery or the blood vessel ingrowth and density of glial scar around the lesion. In conclusion, we have developed and characterized injectable HA-PH-RGD based hydrogel, which represents a suitable material for further combinatorial therapies in neural tissue engineering. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 1129-1140, 2018.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035466
- 003
- CZ-PrNML
- 005
- 20191014110923.0
- 007
- ta
- 008
- 191007s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/jbm.a.36311 $2 doi
- 035 __
- $a (PubMed)29266693
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Zaviskova, Kristyna $u Department of Biomaterials and Biophysical Methods, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic. 2nd Medical Faculty, Charles University, Prague, Czech Republic.
- 245 10
- $a Injectable hydroxyphenyl derivative of hyaluronic acid hydrogel modified with RGD as scaffold for spinal cord injury repair / $c K. Zaviskova, D. Tukmachev, J. Dubisova, I. Vackova, A. Hejcl, J. Bystronova, M. Pravda, I. Scigalkova, R. Sulakova, V. Velebny, L. Wolfova, S. Kubinova,
- 520 9_
- $a Hydrogel scaffolds which bridge the lesion, together with stem cell therapy represent a promising approach for spinal cord injury (SCI) repair. In this study, a hydroxyphenyl derivative of hyaluronic acid (HA-PH) was modified with the integrin-binding peptide arginine-glycine-aspartic acid (RGD), and enzymatically crosslinked to obtain a soft injectable hydrogel. Moreover, addition of fibrinogen was used to enhance proliferation of human Wharton's jelly-derived mesenchymal stem cells (hWJ-MSCs) on HA-PH-RGD hydrogel. The neuroregenerative potential of HA-PH-RGD hydrogel was evaluated in vivo in acute and subacute models of SCI. Both HA-PH-RGD hydrogel injection and implantation into the acute spinal cord hemisection cavity resulted in the same axonal and blood vessel density in the lesion area after 2 and 8 weeks. HA-PH-RGD hydrogel alone or combined with fibrinogen (HA-PH-RGD/F) and seeded with hWJ-MSCs was then injected into subacute SCI and evaluated after 8 weeks using behavioural, histological and gene expression analysis. A subacute injection of both HA-PH-RGD and HA-PH-RGD/F hydrogels similarly promoted axonal ingrowth into the lesion and this effect was further enhanced when the HA-PH-RGD/F was combined with hWJ-MSCs. On the other hand, no effect was found on locomotor recovery or the blood vessel ingrowth and density of glial scar around the lesion. In conclusion, we have developed and characterized injectable HA-PH-RGD based hydrogel, which represents a suitable material for further combinatorial therapies in neural tissue engineering. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 1129-1140, 2018.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kyselina hyaluronová $x chemie $7 D006820
- 650 _2
- $a hydrogely $x chemie $7 D020100
- 650 12
- $a injekce $7 D007267
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mezenchymální kmenové buňky $x cytologie $x účinky léků $7 D059630
- 650 _2
- $a pohybová aktivita $7 D009043
- 650 _2
- $a oligopeptidy $x chemie $7 D009842
- 650 _2
- $a messenger RNA $x genetika $x metabolismus $7 D012333
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a poranění míchy $x patologie $x patofyziologie $7 D013119
- 650 12
- $a regenerace míchy $7 D058630
- 650 _2
- $a tkáňové podpůrné struktury $x chemie $7 D054457
- 650 _2
- $a Whartonův rosol $x cytologie $7 D059631
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Tukmachev, Dmitry $u Department of Biomaterials and Biophysical Methods, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic. 2nd Medical Faculty, Charles University, Prague, Czech Republic.
- 700 1_
- $a Dubisova, Jana $u Department of Biomaterials and Biophysical Methods, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic. 2nd Medical Faculty, Charles University, Prague, Czech Republic.
- 700 1_
- $a Vackova, Irena $u Department of Biomaterials and Biophysical Methods, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Hejcl, Ales $u Department of Biomaterials and Biophysical Methods, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Bystronova, Julie $u Department of Tissue Engineering, Contipro a.s., Dolni Dobrouc, Czech Republic.
- 700 1_
- $a Pravda, Martin $u Department of Tissue Engineering, Contipro a.s., Dolni Dobrouc, Czech Republic.
- 700 1_
- $a Scigalkova, Ivana $u Department of Tissue Engineering, Contipro a.s., Dolni Dobrouc, Czech Republic.
- 700 1_
- $a Sulakova, Romana $u Department of Tissue Engineering, Contipro a.s., Dolni Dobrouc, Czech Republic.
- 700 1_
- $a Velebny, Vladimir $u Department of Tissue Engineering, Contipro a.s., Dolni Dobrouc, Czech Republic.
- 700 1_
- $a Wolfova, Lucie $u Department of Biomaterials and Biophysical Methods, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic. Department of Tissue Engineering, Contipro a.s., Dolni Dobrouc, Czech Republic.
- 700 1_
- $a Kubinova, Sarka $u Department of Biomaterials and Biophysical Methods, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.
- 773 0_
- $w MED00007498 $t Journal of biomedical materials research. Part A $x 1552-4965 $g Roč. 106, č. 4 (2018), s. 1129-1140
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29266693 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191014111347 $b ABA008
- 999 __
- $a ok $b bmc $g 1452126 $s 1074016
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 106 $c 4 $d 1129-1140 $e 20180123 $i 1552-4965 $m Journal of biomedical materials research. Part A $n J Biomed Mater Res $x MED00007498
- LZP __
- $a Pubmed-20191007